Cerevel Therapeutics Holdings, Inc. Debt to Equity Ratio 2021-2024 | CERE
Current and historical debt to equity ratio values for Cerevel Therapeutics Holdings, Inc. (CERE) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cerevel Therapeutics Holdings, Inc. debt/equity for the three months ending March 31, 2024 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-03-31 | $0.56B | $0.56B | 1.00 |
| 2023-12-31 | $0.57B | $0.67B | 0.85 |
| 2023-09-30 | $0.55B | $0.27B | 2.01 |
| 2023-06-30 | $0.54B | $0.35B | 1.55 |
| 2023-03-31 | $0.50B | $0.43B | 1.16 |
| 2022-12-31 | $0.50B | $0.52B | 0.95 |
| 2022-09-30 | $0.49B | $0.60B | 0.81 |
| 2022-06-30 | $0.14B | $0.45B | 0.32 |
| 2022-03-31 | $0.10B | $0.52B | 0.19 |
| 2021-12-31 | $0.11B | $0.58B | 0.19 |
| 2021-09-30 | $0.10B | $0.63B | 0.17 |
| 2021-06-30 | $0.10B | $0.29B | 0.33 |
| 2021-03-31 | $0.07B | $0.34B | 0.20 |
| 2020-12-31 | $0.06B | $0.39B | 0.16 |
| 2020-09-30 | $0.15B | $0.01B | 29.10 |
| 2020-06-30 | $0.15B | $0.01B | 29.22 |
| 2020-03-31 | $0.00B | 0.00 | |
